Journal of Pregnancy and Neonatal Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Perspective - Journal of Pregnancy and Neonatal Medicine (2025) Volume 9, Issue 1

Advances in Fetal Surgery: Techniques and Ethical Considerations

Lauren Levine *

Divisions of Nephrology and Obstetrics, University of Toronto, Canada

*Corresponding Author:
Lauren Levine
Divisions of Nephrology and Obstetrics, University of Toronto, Canada
E-mail: lauren@ut.cn.co

Received: 02-Jan-2025, Manuscript No. AAPNM-25-162855; Editor assigned: 03-Jan-2025, PreQC No. AAPNM-25-162855 (PQ) Reviewed:17-Jan-2025, QC No. AAPNM-25-162855Revised:24-Jan-2025, Manuscript No. AAPNM-25-162855 (R); Published:28-Jan-2025, DOI: 10.35841/aapnm-9.1.249

Citation: Hartmann J. Maternal Immunizations: The Importance of Vaccines During Pregnancy. J Preg Neonatal Med. 2025;9(1):249

Visit for more related articles at Journal of Pregnancy and Neonatal Medicine

Abstract

   

Introduction

Fetal surgery has emerged as a groundbreaking field in medicine, providing the potential to treat certain congenital conditions before birth. The ability to perform surgical interventions in utero has significantly improved outcomes for infants with severe birth defects, allowing for the correction of life-threatening conditions and enhancing the quality of life after birth [1]. While fetal surgery offers significant medical benefits, it also presents numerous ethical challenges that must be carefully considered. This mini-review explores the advances in fetal surgery, highlighting key techniques and ethical issues surrounding the practice.

Advances in Fetal Surgery Techniques

Fetal surgery refers to surgical interventions performed on the fetus during pregnancy, typically before 24 weeks of gestation, although the timing can vary depending on the condition being treated. Advances in both surgical techniques and technologies have made fetal surgery increasingly viable for a range of congenital anomalies. Open fetal surgery involves directly accessing the uterus to treat the fetus. The procedure typically requires the mother to undergo general anesthesia, and the uterus is surgically opened to allow the surgeon to repair the fetus. This technique has been most commonly used for conditions like spina bifida, where surgery can be performed to close the spinal defect in the fetus, preventing further damage and improving neurological outcomes. Studies have shown that this approach can significantly reduce the incidence of paralysis and improve motor function in affected infants [2].

With the advent of fetoscopic surgery, which uses a small camera and specialized instruments inserted through tiny incisions in the mother’s abdomen, minimally invasive fetal surgery has gained traction. This technique allows for the treatment of conditions like twin-to-twin transfusion syndrome (TTTS), where blood flow between identical twins is imbalanced. Fetoscopic surgery involves using laser technology to create selective occlusions of blood vessels, correcting the imbalance without requiring a major incision. Minimally invasive approaches reduce maternal risks and recovery time compared to open fetal surgery, making them attractive alternatives when applicable [3].

Recent research has explored the use of gene therapy and stem cell therapy in the prenatal treatment of conditions like cystic fibrosis and muscular dystrophy. These treatments involve administering genetic material or stem cells to the fetus in utero to correct or manage genetic defects at a molecular level. Although still in experimental stages, these therapies hold the promise of addressing the root causes of congenital diseases rather than just treating the symptoms. For certain conditions like anemia caused by Rh incompatibility, fetal blood transfusions can be performed through a needle inserted into the umbilical cord. This life-saving procedure helps to increase the fetus’s red blood cell count, preventing complications like hydrops fetalis, which can lead to fetal death if untreated [4].

Ethical Considerations in Fetal Surgery

Despite the remarkable advancements in fetal surgery, the field raises a number of ethical dilemmas that must be carefully navigated. These include questions surrounding maternal consent, fetal personhood, and the long-term consequences of in utero interventions. One of the primary ethical concerns is ensuring that the mother provides informed consent for the procedure. Fetal surgery often carries risks to both the mother and the fetus, including complications such as premature labor, infection, and potential fetal injury. The decision to proceed with fetal surgery must be made with careful consideration of the risks to the mother’s health and the potential benefits for the fetus. Informed consent is especially challenging when the procedure is experimental or the outcomes uncertain, as in the case of gene therapy or stem cell treatments [5].

Fetal surgery also raises questions about the moral status of the fetus. Different cultures and legal systems have varying views on fetal personhood, with some regarding the fetus as a separate individual with rights, while others see the fetus as part of the mother’s body. Ethical questions arise about when the fetus is considered a person, especially in cases where fetal surgery may prevent a condition that would result in death or significant disability after birth. This issue is particularly relevant when weighing the risks of surgery and the potential outcomes for the fetus [6]. Many fetal surgeries are performed in response to conditions that may have uncertain or variable outcomes. For instance, in spina bifida, the success of surgery in improving mobility and cognitive function is not guaranteed, and some infants may still face significant disabilities after birth. The ethical challenge here is balancing the potential benefits of surgery with the unknowns regarding the long-term outcomes, particularly when considering the impact on the child’s quality of life [7].

As fetal surgery becomes more advanced, it also raises concerns about access to care. These procedures are highly specialized and often available only at major medical centers, meaning that only a small subset of pregnant women have access to these treatments. Additionally, the high cost of fetal surgery can limit its accessibility to wealthier individuals or those with adequate insurance coverage, raising issues of healthcare equity. Finally, the decision to undergo fetal surgery can have significant psychosocial consequences for families. Parents may experience emotional and psychological stress as they navigate the complex decision-making process. The potential outcomes, both positive and negative, can lead to feelings of uncertainty, guilt, and anxiety. Counseling and support for parents are critical components of the decision-making process in fetal surgery [8-10].

Conclusion

Fetal surgery represents a major advancement in the treatment of congenital conditions, offering the potential to significantly improve neonatal outcomes and reduce the burden of lifelong disabilities. Techniques such as open fetal surgery, fetoscopic surgery, and emerging therapies like gene therapy and stem cell treatments have made it possible to intervene in utero, correcting conditions before birth. However, these advances are accompanied by complex ethical challenges, including issues of maternal consent, fetal personhood, and access to care. As the field of fetal surgery continues to evolve, it is essential to address these ethical concerns to ensure that interventions are carried out in a manner that is both medically effective and ethically responsible. Continued research, alongside ethical dialogue, will help shape the future of fetal surgery, ensuring that it remains a compassionate and equitable option for families in need.

References

  1. Moldenhauer LM, Hull ML, Foyle KL, et al. Immune–Metabolic Interactions and T Cell Tolerance in Pregnancy. J Immunol. 2022;209(8):1426-36.

    2. Indexed at, Google Scholar, Cross Ref

  2. Valencia?Ortega J, Saucedo R, Pena?Cano MI, et al. Immune tolerance at the maternal?placental interface in healthy pregnancy and pre?eclampsia. J Obstet Gynaecol Res. 2020;46(7):1067-76.

    3. Indexed at, Google Scholar, Cross Ref

  3. True H, Blanton M, Sureshchandra S, et al. Monocytes and macrophages in pregnancy: The good, the bad, and the ugly. Immunol Rev. 2022;308(1):77-92.

    4. Indexed at, Google Scholar, Cross Ref

  4. Ta?ska K, Gietka-Czernel M, Glinicki P, et al. Thyroid autoimmunity and its negative impact on female fertility and maternal pregnancy outcomes. Front Endocrinol (Lausanne). 2023;13:1049665.

    5. Indexed at, Google Scholar, Cross Ref

  5. Borgers JS, Heimovaara JH, Cardonick E, et al. Immunotherapy for cancer treatment during pregnancy. Lancet Oncol. 2021;22(12):550-61.

    6. Indexed at, Google Scholar, Cross Ref

  6. Abu-Raya B, Michalski C, Sadarangani M, et al. Maternal immunological adaptation during normal pregnancy. Front Immunol. 2020;11:575197.

    7. Indexed at, Google Scholar, Cross Ref

  7. Fuhler GM. The immune system and microbiome in pregnancy. Best Pract Res Clin Gastroenterol. 2020;44:101671.

    8. Indexed at, Google Scholar, Cross Ref

  8. Morelli AE, Sadovsky Y. Extracellular vesicles and immune response during pregnancy: A balancing act. Immunol Rev. 2022;308(1):105-22.

    9. Indexed at, Google Scholar, Cross Ref

  9. Gonzalez CA, Gonzalez S. Fetal and neonatal allo-immune response. Transfus Apher Sci. 2020;59(5):102945.

    10. Indexed at, Google Scholar, Cross Ref

  10. Yousefzadeh Y, Soltani-Zangbar MS, Hemmatzadeh M, et al. Fetomaternal immune tolerance: crucial mechanisms of tolerance for successful pregnancy in humans. Immunol Invest. 2022;51(4):1108-25.

    11. Indexed at, Google Scholar, Cross Ref

Get the App